Dear Friends and Colleagues,
In the last decade the introduction of biotechnology drugs has given rise to a revolution in the medical world involving the fields of Rheumatology and Autoimmunity.
These new targeted therapies are more effective and in general less toxic than the traditional drugs improving the prognosis of patients, but raising some ethical issues due to their high costs.
In addition, the identification and the development of these molecules let us identify new immunological targets and pathways which increased our knowledge on the pathogenesis of rheumatic and autoimmune diseases.
As expected, the rapid achievement of a huge number of clinical as well as mechanistic data raised a number of controversial issues which we have to approach and resolve as soon as possible in order to allow the continuous progression of science.
Join us for the first international congress on Controversies in Rheumatology and Autoimmunity (CORA 2011) to discuss controversial aspect in pathogenesis, clinical features, outcomes and the treatment of rheumatic and autoimmune diseases.
CORA 2011 aims to focus on the practical issues faced by specialists in the field of rheumatic and autoimmune diseases and will provide essential knowledge for congress participants to put into practice in their daily lives. The scientific program will include clinical debates and discussions as well as educational sessions.
Florence, the Venue we have chosen, is located in Tuscany, one of the richest regions in Italy, in terms of history, culture, flavours, perfumes, and colours. We look forward to welcoming you to this lovely location and to a very interesting Congress.
Prof. Andrea Doria (Italy)
Dr. Piercarlo Sarzi-Puttini (Italy)
Prof. Zoltan Szekanecz (Hungary)
Prof. Yehuda Shoenfeld (Israel)